How Will FDA Approval of COVID Vaccines in Younger Kids Impact Pfizer?

Children ages 5 through 11 will now be able to receive the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). In this Motley Fool Live video recorded on Oct. 27, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how U.S. Food and Drug Administration (FDA) authorization of the vaccine in younger kids will impact Pfizer.

Continue reading

Source Fool.com